Interleukin-28B (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus

BACKGROUND: The success of treatment of chronic hepatitis C (CHC) with pegylated interferon-α (PEG-IFN-α) and ribavirin (RBV) is affected by several host, viral, and treatment factors. This study was designed to describe the association of interleukin (IL) 28B genotypes for rs12979860 with sustained...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalantari, Hamid, Tavakoli, Tahmine, Bagherpour, Bahram, Honarmand, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310080/
https://www.ncbi.nlm.nih.gov/pubmed/25657752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310080/
https://www.ncbi.nlm.nih.gov/pubmed/25657752

Ejemplares similares